| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8316657 | Clinica Chimica Acta | 2011 | 8 Pages |
Abstract
Bezafibrate and atorvastatin improve atherogenic dyslipidemia in considerably different ways. Extrapolating from the present data, we presume that the combination of these drugs may contribute to reduce LDL-C/HDL-C ratio effectively as well as lowering concentrations of serum triglyceride.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Masa-aki Kawashiri, Junji Kobayashi, Atsushi Nohara, Tohru Noguchi, Hayato Tada, Chiaki Nakanishi, Akihiro Inazu, Hiroshi Mabuchi, Masakazu Yamagishi,